Stockholm - Delayed Quote SEK

Oncopeptides AB (publ) (ONCO.ST)

Compare
1.5560 +0.0280 (+1.83%)
At close: 5:29:42 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-244,467.0000
-279,493.0000
-420,509.0000
-1,516,391.0000
-1,296,509.0000
Investing Cash Flow
-1.0000
-116.0000
-2,507.0000
-339.0000
-20,127.0000
Financing Cash Flow
260,291.0000
106,889.0000
392,402.0000
1,034,030.0000
1,323,461.0000
End Cash Position
249,418.0000
173,407.0000
344,515.0000
362,187.0000
840,255.0000
Capital Expenditure
-2,628.0000
-116.0000
-2,507.0000
-339.0000
-17,180.0000
Issuance of Capital Stock
1,316,836.0000
--
435,611.0000
1,116,488.0000
1,422,952.0000
Issuance of Debt
--
116,024.0000
--
--
--
Repayment of Debt
-3,956.0000
--
--
--
-14,260.0000
Free Cash Flow
-244,583.0000
-279,609.0000
-423,016.0000
-1,516,730.0000
-1,313,689.0000
12/31/2020 - 2/22/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers